A Phase Ii Study Of Regorafenib In Patients With Thymic Epithelial Tumours Previously Treated With Chemotherapy.

Matteo Perrino,Silvia Bozzarelli,Paolo Andrea Zucali,Tommaso De Pas,Matteo Simonelli,Fabio De Vincenzo,Fabio Conforti,Pasquale Persico,Chiara Miggiano,Nadia Cordua,A. Cioffi,Simona Sala,Federica Mrakic Sposta,Laura Giordano,Armando Santoro

JOURNAL OF CLINICAL ONCOLOGY（2018）

引用 3|浏览43

暂无评分

摘要

8579Background: Angiogenesis has an important role in thymic epithelial tumours (TETs); VEGF, PDGF and PDGFRα are overexpressed in TETs, and VEGF expression and microvessel density are associated w...

查看译文

关键词

thymic epithelial tumours,regorafenib,chemotherapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要